Results of relevant dementia cognition, global stage, quality of life and activities of daily living scores over 6 months
| Assessment month end | MMSE | CDR | GDS | FAST | QoL-AD (patient) | QoL-AD (proxy) | Barthel | NPI severity | NPI distress |
| Sept 2019 | 18 | 2 | 5 | 6.2 | 47 | 19 | 85 | – | – |
| Oct 2019 | 17 | 2 | 5 | 6.2 | 42 | 33 | 85 | 18 | 25 |
| Nov 2019 | 18 | 2 | 5 | 6.2 | 42 | 35 | 85 | 17 | 31 |
| Jan 2020 | 13 | 2 | 6 | 6.6 | 45 | 32 | 75 | 11 | 15 |
| Feb 2020 | 16 | 2 | 6 | 6.6 | 45 | 30 | 80 | 17 | 16 |
| Mar–Nov 2020 | No further in-person assessments | ||||||||
MMSE scored out of 30.71 72
CDR scale ratings: 0=normal; 0.5=very mild; 1=mild; 2=moderate; 3=severe.73
GDS staging levels: 1=no cognitive decline; 2=very mild cognitive decline; 3=mild cognitive decline; 4=moderate cognitive decline; 5=moderately severe cognitive decline; 6=severe cognitive decline; 7=very severe cognitive decline. FAST levels: 1=normal adult; 2=normal older adult; 3=early AD; 4=mild AD; 5=moderate AD; 6=moderately severe AD; 7=severe AD.74 75
Barthel Index of Activities of Daily Living scale (Barthel’s): out of 100.76
NPI maximum score 36 for severity and 60 for caregiver distress.77
QoL-AD scale with a maximum score of 52.78
.AD, Alzheimer's disease; CDR, Clinical Dementia Rating; FAST, Functional Assessment Staging; GDS, Global Deterioration Scale; MMSE, Mini-Mental State Examination; NPI, Neuropsychiatric Inventory; QoL-AD, Quality of Life in Alzheimer’s Disease.